Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited has announced the appointment of John Ciccio as a director, effective November 7, 2025. This announcement, detailed in the Initial Director’s Interest Notice, indicates that Ciccio currently holds no securities or interests in contracts related to the company. The appointment is part of MedAdvisor’s strategic efforts to strengthen its leadership team, potentially impacting its operational dynamics and stakeholder relations.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, focusing on providing digital solutions to enhance medication management and adherence. The company primarily offers platforms and services that connect patients, pharmacies, and healthcare providers to improve health outcomes and streamline pharmaceutical care.
Average Trading Volume: 879,399
Technical Sentiment Signal: Sell
Current Market Cap: A$16.45M
See more insights into MDR stock on TipRanks’ Stock Analysis page.